Literature DB >> 27172279

Defensive Medicine in U.S. Spine Neurosurgery.

Ryan S Din1, Sandra C Yan, David J Cote, Michael A Acosta, Timothy R Smith.   

Abstract

STUDY
DESIGN: Observational cross-sectional survey.
OBJECTIVE: To compare defensive practices of U.S. spine and nonspine neurosurgeons in the context of state medical liability risk. SUMMARY OF BACKGROUND DATA: Defensive medicine is a commonly reported and costly phenomenon in neurosurgery. Although state liability risk is thought to contribute greatly to defensive practice, variation within neurosurgical specialties has not been well explored.
METHODS: A validated, online survey was sent via email to 3344 members of the American Board of Neurological Surgeons. The instrument contained eight question domains: surgeon characteristics, patient characteristics, practice type, insurance type, surgeon liability profile, basic surgeon reimbursement, surgeon perceptions of medical legal environment, and the practice of defensive medicine.
RESULTS: The overall response rate was 30.6% (n = 1026), including 499 neurosurgeons performing mainly spine procedures (48.6%). Spine neurosurgeons had a similar average practice duration as nonspine neurosurgeons (16.6 vs 16.9 years, P = 0.64) and comparable lifetime case volume (4767 vs 4,703, P = 0.71). The average annual malpractice premium for spine neurosurgeons was similar to nonspine neurosurgeons ($104,480.52 vs $101,721.76, P = 0.60). On average, spine neurosurgeons had a significantly higher rate of ordering labs, medications, referrals, procedures, and imaging solely for liability concerns compared with nonspine neurosurgeons (89.2% vs 84.6%, P = 0.031). Multivariate analysis revealed that spine neurosurgeons were roughly 3 times more likely to practice defensively compared with nonspine neurosurgeons (odds ratio, OR = 2.9, P = 0.001) when controlling for high-risk procedures (OR = 7.8, P < 0.001), annual malpractice premium (OR = 3.3, P = 0.01), percentage of patients publicly insured (OR = 1.1, P = 0.80), malpractice claims in the last 3 years (OR = 1.13, P = 0.71), and state medical-legal environment (OR = 1.3, P = 0.37).
CONCLUSION: State-based medical legal environment is not a significant driver of increased defensive medicine associated with neurosurgical spine procedures. LEVEL OF EVIDENCE: 3.

Entities:  

Mesh:

Year:  2017        PMID: 27172279     DOI: 10.1097/BRS.0000000000001687

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  6 in total

1.  Removal of Non-economic Damage Caps Is Not Associated with Reductions in Early Imaging for Low Back Pain.

Authors:  Christopher J Dy; Michael F Pesko; Matthew Keller; Elizabeth Sepper; Margaret A Olsen
Journal:  HSS J       Date:  2019-01-03

2.  Socio-Demographic, Professional and Institutional Characteristics That Make Romanian Doctors More Prone to Malpractice Complaints.

Authors:  Bianca Hanganu; Magdalena Iorga; Lavinia Maria Pop; Beatrice Gabriela Ioan
Journal:  Medicina (Kaunas)       Date:  2022-02-14       Impact factor: 2.430

Review 3.  The occurrence, types, reasons, and mitigation strategies of defensive medicine among physicians: a scoping review.

Authors:  Edris Kakemam; Morteza Arab-Zozani; Pouran Raeissi; Ahmed Hassan Albelbeisi
Journal:  BMC Health Serv Res       Date:  2022-06-20       Impact factor: 2.908

4.  Medical Malpractice Claims and Mitigation Strategies Following Spine Surgery.

Authors:  Keith L Jackson; Jacob Rumley; Matthew Griffith; Timothy R Linkous; Uzondu Agochukwu; John DeVine
Journal:  Global Spine J       Date:  2020-08-07

5.  Spine neurosurgeons facing the judicialization of their profession: disenchantment and alteration of daily practice-a qualitative study.

Authors:  Antoine Guillain; Anne-Hélène Moncany; Olivier Hamel; Carole Gerson; Renaud Bougeard; Grégory Dran; Bertrand Debono
Journal:  Acta Neurochir (Wien)       Date:  2020-03-27       Impact factor: 2.216

6.  How defensive medicine is defined in European medical literature: a systematic review.

Authors:  Nathalie Baungaard; Pia Ladeby Skovvang; Elisabeth Assing Hvidt; Helle Gerbild; Merethe Kirstine Andersen; Jesper Lykkegaard
Journal:  BMJ Open       Date:  2022-01-20       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.